NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker


– physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic.

– Early detection of COVID-19 decompensation in patients is complicated by infrequent and non-specific clinical data. The first-in-kind tool will collect and analyzes continuous physiologic data could provide early clinical indicators of COVID-19 decompensation.